Oracion, Joycil B.

HRN: 27-21-65  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/22/2025
METRONIDAZOLE 500MG (TAB)
07/22/2025
07/28/2025
PO
500mg
TID X 7 Days
Thickly MSAF
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: